Related Experiment Video

Updated: Aug 7, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Invasive fungal infection--laboratory diagnosis and antifungal treatment

Pei Lan Shao1, Li Min Huang, Po Ren Hsueh

  • 1Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|June 20, 2006
PubMed

Insights

Invasive fungal infections (IFIs) are rising, posing diagnostic and treatment challenges. New diagnostic tools and antifungal drugs offer improved outcomes, but combination therapy needs further research.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Invasive fungal infections (IFIs) are increasing due to immunocompromised populations and broad-spectrum antibiotic use.
  • High morbidity and mortality rates persist, with diagnosis and treatment remaining challenging.
  • Conventional diagnostic methods (cultures, histopathology) have limitations like insensitivity or invasiveness.

Purpose of the Study:

  • To review recent advances in the diagnosis and treatment of invasive fungal infections.
  • To highlight improvements in diagnostic techniques and novel antifungal agents.
  • To discuss the potential of combination antifungal strategies.

Main Methods:

  • Review of current literature on IFIs.
  • Analysis of innovative diagnostic techniques, including antigen and DNA detection for invasive aspergillosis.
  • Evaluation of newer antifungal agents (lipid amphotericin B, azoles, echinocandins) and combination therapies.

Main Results:

  • Innovative diagnostic methods offer improved sensitivity and reduced invasiveness compared to conventional techniques.
  • Newer antifungal agents exhibit lower toxicity or enhanced activity against specific fungi.
  • Combination antifungal therapy shows potential for additive or synergistic effects.

Conclusions:

  • Advances in diagnostics and therapeutics offer promise for improving outcomes in IFIs.
  • Combination antifungal strategies require further investigation through large-scale randomized clinical trials to confirm efficacy.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...